New York, NY -- (SBWIRE) -- 12/18/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Standard Pacific Corp (NYSE:SPF), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Cal Dive International, Inc (NYSE:DVR), Dendreon Corporation (NASDAQ:DNDN)
Standard Pacific Corp (NYSE:SPF) the stock opened the session at $80.7 but then moved to $8.03. At that price, the stock showed a negative performance of -0.37%. Standard Pacific Corp. is a geographically diversified business spans many of the housing markets, including metropolitan markets in California, Florida, the Carolinas, Texas, Arizona, and Colorado. The Company operates in two principal businesses: homebuilding and financial services (consisting of its mortgage financing and title operations).
Will SPF Get Buyers Even After The Recent Rally? Find Out Here
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) opened the session at $2.82 and closed the session at $2.68. The stock showed a negative performance of -4.96% in previous trading session. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its docosanol 10% cream, sold in the United States and Canada as Abreva by its marketing partner GlaxoSmithKline Consumer Healthcare,
Has AVNR Found The Bottom And Ready To Gain Momentum? Find Out Here
Cal Dive International, Inc (NYSE:DVR) opened the session at $1.72 and closed the session at $1.70. The stock showed a negative performance of -1.16% in previous trading session. The beta of the stock remained 2.21. Cal Dive International, Inc. (CDI) is a marine contractor that provides manned diving, pipelay and pipe burial, platform installation and platform salvage services to a diverse customer base in the offshore oil and natural gas industry. CDI offers its customers services on an integrated basis for more complex offshore projects. Its global footprint encompasses operations on the Gulf of Mexico Outer Continental Shelf (OCS), the North-eastern United States, Latin America, Southeast Asia, China, Australia, the Middle East and the Mediterranean.
Why Should Investors Buy DVR After the Recent Fall? Just Go Here and Find Out
Dendreon Corporation (NASDAQ:DNDN) the stock decreased -0.91% and finished the session at $3.28. The beta of the stock remained 5.04. Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may significantly improve cancer treatment options for patients. The Company's product portfolio includes active cellular immunotherapies and a small molecule product candidate that could be applicable to treating multiple types of cancers. PROVENGE (sipuleucel-T), is the Company's first commercialized product approved by the United States Food and Drug Administration (FDA),
Will DNDN Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)